Article info

PDF

Original research article
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis

Authors

  1. Correspondence to Dr James B Chung; chung{at}amgen.com
View Full Text

Citation

Boedigheimer MJ, Martin DA, Amoura Z, et al
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis

Publication history

  • Received 20 April 2017
  • Revision received 21 June 2017
  • Accepted 24 June 2017
  • Published in print 1 September 2017.
  • Published online 14 September 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.